VANCOUVER, BC — (BUSINESS WIRE) — AbCellera (Nasdaq: ABCL) announced today that it has entered into a multi-year, multi-target strategic collaboration with AbbVie Inc. (NYSE: ABBV). The partnership will leverage AbCellera’s antibody discovery… Read More
VANCOUVER, BC — /PRNewswire/ — EmeTerm, the anti-nausea wristband developed by WAT Medical Enterprise, Ltd., received its FDA clearance in 2018 as a medical device that manages nausea-induced vomiting. In December… Read More
BURNABY, BC — Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is excited to announce… Read More
Company is developing bespoke radiopharmaceuticals with capital efficient and rapid approach Proceeds to support progression of five candidates into the clinic, expansion of early-stage programs, accelerated growth of team, and… Read More
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common… Read More
